Your provider can assess whether a dose pause or rate adjustment is appropriate
Treatment should be started safely and monitored over time, both for effectiveness and tolerability
Ozempic is not known to directly affect reproductive hormones or the menstrual cycle through its mechanism as a GLP-1 receptor agonist
Understanding this potential side effect, even if it is relatively rare, is important for those taking the medication
Combining tirzepatide treatment with dietary management, physical activity, and regular provider follow-ups optimizes results
2 New classes of medications, such as the dipeptidyl peptidase-4 (DPP-4) inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, and sodium-glucose cotransporter- 2 (SGLT-2) inhibitors, specifically target some of the more recently identified defects described in the ominous octet to help manage uncontrolled hyperglycemia